Lawyer opposes Allergan’s bid for interlocutory appeal in FCA suit
18-01-2021
Fed Circuit remands Allergan inventorship dispute
11-11-2020
FTC demands AbbVie divests Crohn’s treatment in Allergan buyout
07-09-2020
rafapress / Shutterstock.com
A California judge has allowed a patent attorney to proceed with his claims against Allergan which allege the pharmaceutical company fraudulently obtained patents to monopolise pricing.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Allergan, False Claims Act, Zachary Silbersher, patents, Namenda XR, Namzaric, fraud, monopoly
